Literature DB >> 5299668

Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 4.

P Atanasiu, D J Dean, K Habel, M M Kaplan, H Koprowski, P Lépine, C Serié.   

Abstract

Early and persistent antibody is needed for maximum protection to be afforded to persons severely exposed to rabies. With vaccine alone, detectable antibody production takes 7-10 days, and the passive antibody introduced with antirabies serum or gamma-globulin is commonly used to fill this gap. However, administration of antirabies serum or gamma-globulin with vaccine interferes with the antigenic action of the vaccine.The studies reported in this paper provide further evidence that the interfering effect of serum can be overcome by giving booster doses of vaccine, as recommended by the WHO Expert Committee on Rabies, 10 and 20 days after the end of the usual 12- to 14-dose series of vaccine inoculations. While the results do not clearly indicate whether a single booster dose might be sufficient, the authors consider the second booster useful to ensure both degree and length of antibody duration.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5299668      PMCID: PMC2476304     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 3.

Authors:  P ATANASIU; D A CANNON; D J DEAN; J P FOX; K HABEL; M M KAPLAN; R E KISSLING; H KOPROWSKI; P LEPINE; F PEREZ GALLARDO
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

2.  Laboratory techniques in rabies. Habel test for potency.

Authors:  K Habel
Journal:  Monogr Ser World Health Organ       Date:  1966

3.  Laboratory techniques in rabies. Potency-test requirements of the United States National Institutes of Health (NIH).

Authors:  E B Seligmann
Journal:  Monogr Ser World Health Organ       Date:  1966

4.  Human rabies after antiserum and vaccine postexposure treatment. Case report and review.

Authors:  J A Anderson; F T Daly; J C Kidd
Journal:  Ann Intern Med       Date:  1966-06       Impact factor: 25.391

5.  Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. II.

Authors:  P ATANASIU; M BAHMANYAR; M BALTAZARD; J P FOX; K HABEL; M M KAPLAN; R E KISSLING; A KOMAROV; H KOPROWSKI; P LEPINE; F PEREZ GALLARDO; M SCHAEFFER
Journal:  Bull World Health Organ       Date:  1957       Impact factor: 9.408

6.  Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons.

Authors:  P ATANASIU; M BAHMANYAR; M BALTAZARD; J P FOX; K HABEL; M M KAPLAN; R E KISSLING; A KOMAROV; H KOPROWSKI; P LEPINE; F PEREZ GALLARDO; M SCHAEFFER
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

  6 in total
  9 in total

1.  Local infiltration of rabies immunoglobulins without systemic intramuscular administration: An alternative cost effective approach for passive immunization against rabies.

Authors:  Omesh Kumar Bharti; Shampur Narayan Madhusudana; Pyare Lal Gaunta; Ashwin Yajaman Belludi
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Human diploid-cell-culture vaccine for rabies prophylaxis.

Authors:  F Y Aoki
Journal:  Can Med Assoc J       Date:  1979-05-05       Impact factor: 8.262

3.  Injecting rabies immunoglobulin (RIG) into wounds only: A significant saving of lives and costly RIG.

Authors:  Omesh Kumar Bharti; Shampur Narayan Madhusudana; Henry Wilde
Journal:  Hum Vaccin Immunother       Date:  2017-02-22       Impact factor: 3.452

Review 4.  The vaccination of man and other animals against rabies.

Authors:  J Crick
Journal:  Postgrad Med J       Date:  1973-08       Impact factor: 2.401

5.  Rabies immune globulin of human origin: preparation and dosage determination in non-exposed volunteer subjects.

Authors:  V J Cabasso; J C Loofbourow; R E Roby; W Anuskiewicz
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

6.  Effects of homologous or heterologous antiserum on neutralizing-antibody response to rabies vaccine.

Authors:  B G Archer; R E Dierks
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

Review 7.  Antiviral therapy.

Authors:  H Stalder
Journal:  Yale J Biol Med       Date:  1977 Sep-Oct

8.  Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis.

Authors:  Paola De Benedictis; Andrea Minola; Elena Rota Nodari; Roberta Aiello; Barbara Zecchin; Angela Salomoni; Mathilde Foglierini; Gloria Agatic; Fabrizia Vanzetta; Rachel Lavenir; Anthony Lepelletier; Emma Bentley; Robin Weiss; Giovanni Cattoli; Ilaria Capua; Federica Sallusto; Edward Wright; Antonio Lanzavecchia; Hervé Bourhy; Davide Corti
Journal:  EMBO Mol Med       Date:  2016-04-01       Impact factor: 12.137

Review 9.  The Route of Administration of Rabies Vaccines: Comparing the Data.

Authors:  Deborah J Briggs; Susan M Moore
Journal:  Viruses       Date:  2021-06-27       Impact factor: 5.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.